Percussionaire

What Percussionaire does

Percussionaire was a medical device company founded in 1989 and headquartered in Sandpoint, Idaho, that developed and manufactured Intrapulmonary Percussive Ventilation (IPV) therapy hardware used in respiratory care. Its core product line centered on IPV devices that deliver percussive ventilation to mobilize secretions and support gas exchange in patients across neonatal, pediatric, and adult acute care settings. The company maintained a workforce of 51-100 employees and operated as a focused, single-product-category respiratory hardware specialist for over three decades before being acquired by Sentec on February 6, 2024.

The business model is hardware-led medical device sales: Percussionaire sold capital equipment and associated consumables to hospital systems, academic medical centers, and specialized care facilities via a sales-led go-to-market motion supplemented by clinical education channels including webinars, peer-reviewed publications, and in-person events. Pricing was contact-based rather than publicly disclosed, consistent with enterprise medical capital equipment procurement. Customer segmentation was vertical, anchored in neonatal and pediatric intensive care as the primary use case, with secondary positioning across acute respiratory care, diagnostic sleep medicine, home ventilation management, and anesthesia/post-operative care.

Following the February 2024 acquisition by Sentec, Percussionaire's IPV platform was integrated into Sentec's broader noninvasive respiratory monitoring portfolio, combining Intrapulmonary Percussive Ventilation with Transcutaneous Monitoring (tCOM+) and Electrical Impedance Tomography (LuMon System) to offer a three-modality respiratory care stack. The IPV 1 — featuring a Unified Connector, streamlined interface, and lightweight design — was launched as the next-generation device under the combined Sentec/Percussionaire brand. Distribution was simultaneously internationalized through Sentec's direct customer service channels in North America, the UK, and Switzerland, alongside distributor networks across Australia, Austria, Germany, Italy, Japan, and Turkey. Percussionaire now operates as a subsidiary brand of Sentec AG rather than as an independent entity.

Name

Percussionaire

Legal name

Percussionaire

Website

https://percussionaire.com

Company type

Private

Founded year

1989

Operating status

Acquired

Headcount range

51–100 employees

Short description

Percussionaire, founded in 1989 in Sandpoint, Idaho, developed and manufactured Intrapulmonary Percussive Ventilation (IPV) medical devices for hospital and home respiratory care. Acquired by Sentec in February 2024, its IPV line now sits alongside Sentec's TCM and EIT monitoring platforms.

Ownership category

akta.pro rank

Product category

Respiratory Care Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

akta.pro secondary industries

Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

Keywords

• Respiratory care devices
• Intrapulmonary percussive ventilation
• Medical ventilation equipment
• Respiratory therapy devices
• Noninvasive respiratory monitoring

Headquarters

HQ city

Sandpoint

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of medical monitoring and ventilation devices including tCOM+ for transcutaneous monitoring, LuMon System for EIT, and IPV 1 for intrapulmonary percussive ventilation. Percussionaire's IPV therapy technology was acquired by Sentec and continues as part of Sentec's product portfolio.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Percussionaire manufactured and developed respiratory care products centered on Intrapulmonary Percussive Ventilation (IPV) therapy. Its portfolio includes the IPV® 1 ventilation device, the LuMon™ System for Electrical Impedance Tomography (EIT), and the tCOM+ transcutaneous monitoring device, providing comprehensive noninvasive respiratory monitoring and ventilation solutions for neonatal, pediatric, and adult acute care settings.

Product overview

Percussionaire, acquired by Sentec in February 2024, offers a portfolio of respiratory monitoring and ventilation products. The core offerings include the IPV® 1 (Intrapulmonary Percussive Ventilation device), the LuMon™ System for Electrical Impedance Tomography (EIT), and the tCOM+ transcutaneous monitoring device. These products work together to provide comprehensive respiratory care solutions: TCM enables continuous noninvasive monitoring between blood gas readings, EIT visualizes regional lung function at the bedside, and IPV delivers percussive ventilation therapy. The portfolio serves neonatal, pediatric, and adult acute care settings.

Differentiator

Problem solved

Functional benefit

Products and services

• IPV® 1 Intrapulmonary Percussive Ventilation device with a new Unified Connector for efficient provider workflows, a streamlined patient-friendly interface, and a lightweight design for simplified clinical experience. Builds on the legacy of IPV therapy for clinical respiratory care.
• LuMon™ System
• tCOM+

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• PercussionairecoreStrategic or Co-development Partner · 6 February 2024Percussionaire has been acquired by Sentec. The acquisition brings IPV (Intrapulmonary Percussive Ventilation) therapy technology into Sentec's portfolio, combining it with Sentec's existing transcutaneous monitoring (TCM) and electrical impedance tomography (EIT) capabilities to provide comprehensive noninvasive respiratory monitoring solutions.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Dräger: Dräger (Drägerwerk) is a global medical and safety technology company with a broad ICU ventilation and patient monitoring portfolio that overlaps with Percussionaire's IPV, TCM, and EIT product categories. As an incumbent, Dräger competes for the same hospital respiratory capital budgets.
• Getinge: Getinge offers a broad portfolio of respiratory care, anesthesia, and ICU solutions including ventilators and patient monitoring. As an established medtech incumbent, it competes for hospital respiratory device contracts alongside Percussionaire.
• Philips Respironics: Philips Respironics provides ventilation and sleep-disordered breathing therapy devices, including BiPAP and CPAP platforms, overlapping with Percussionaire's home ventilation and respiratory therapy positioning.
• Medtronic: Medtronic's Patient Monitoring and Respiratory Interventions businesses include ventilation and airway management products that overlap with Percussionaire's mechanical ventilation and respiratory monitoring offerings.
• Fisher & Paykel Healthcare: Fisher & Paykel Healthcare manufactures respiratory care products including humidification systems, neonatal CPAP, and high-flow therapy devices, comparable to Percussionaire's neonatal/pediatric respiratory care focus.
• Nihon Kohden: Nihon Kohden is a Japanese medical electronics company specializing in patient monitoring and clinical measurement devices, comparable to the TCM and EIT monitoring aspects of the Percussionaire/Sentec platform.

Direct peers

• Hamilton Medical: Hamilton Medical specializes in mechanical ventilation systems for ICU and transport settings, directly competing with Percussionaire's IPV ventilation therapy line in hospital critical care.
• ResMed: ResMed is a global leader in sleep-disordered breathing and home ventilation devices (CPAP, BiPAP, ventilators), directly comparable to Percussionaire's home ventilation management segment and broader respiratory care focus.
• Vyaire Medical: Vyaire Medical specializes in respiratory diagnostics and ventilation products, including consumables and devices for acute and chronic respiratory care, making it a directly comparable niche peer in the respiratory device space.

Others

• Sentec AG: Sentec is the Swiss parent company that acquired Percussionaire in February 2024; it is directly relevant as the strategic acquirer integrating IPV into its TCM/EIT noninvasive respiratory monitoring portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/percussionaire
• Facebookfacebook.com/percussionaire
• LinkedInlinkedin.com/company/percussionaire

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Percussionaire